Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma companies.

Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

Psychiatry is often treated as separate to the rest of medicine. It's time to bring psychiatry into the era of precision medicine.

Discover how AI and agentic workflows help chemists accelerate drug design, generate hypotheses, and analyze data in real ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

Scientists are increasingly realizing the potential of biomaterials to help with many tasks. A key area biomaterials are being used in is tissue engineering and regeneration, something several ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...